Cain Michael T, Firstenberg Michael S, Cleveland Joseph C
Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado Aurora, CO.
William Novick Global Cardiac Alliance Aurora, CO.
US Cardiol. 2021 Sep 24;15:e16. doi: 10.15420/usc.2021.11. eCollection 2021.
For nearly 60 years, there have been two surgical treatment options for individuals with severe advanced heart failure: heart transplantation or implantation of a left ventricular assist device. As these fields have advanced in parallel, improvements in surgical technique, device development, and patient selection have improved outcomes for both therapies. Development of a comprehensive approach to the management of the most severe forms of advanced heart failure requires a deep understanding of both heart transplantation and durable ventricular assistance, including recent advancements in both fields. This article will review the substantial progress in the fields of heart transplantation and mechanical left ventricular assistance, including recent changes to organ allocation prioritization and left ventricular assist device evaluation, both of which have dramatically influenced practice in these fields.
近60年来,对于患有严重晚期心力衰竭的患者,一直有两种外科治疗选择:心脏移植或植入左心室辅助装置。随着这些领域的并行发展,手术技术的改进、设备的研发以及患者选择的优化都提高了这两种治疗方法的疗效。制定一种全面的方法来管理最严重形式的晚期心力衰竭,需要深入了解心脏移植和持久心室辅助这两个方面,包括这两个领域的最新进展。本文将回顾心脏移植和机械左心室辅助领域的重大进展,包括器官分配优先级和左心室辅助装置评估的最新变化,这两者都对这些领域的实践产生了重大影响。